Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
180 participants
INTERVENTIONAL
2019-08-22
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM
NCT03090464
Empowering Patients With Diabetes and Their Family Members: Assessing the Impact of Free Informative Mobile Messages
NCT06176495
Diabetes Self-Management & Support LIVE
NCT02040038
Development and Evaluation of a Culturally Sensitive Structured Diabetes Self-Management Program for People With Type 2 Diabetes Residing in Qatar
NCT06948370
Video-Assisted Instruction in Type 2 Diabetes Patients
NCT05926388
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention arm
For the subjects using the app (intervention group): The mobile app team shall do the following:
* Educate/train patients on app usage
* Patients will be subscribed to the app and their profile on the app will be created
* Subjects will log in their blood sugar readings and communicate with the mobile app team (educators and physician) via the app
* Additionally patients will be placed on a diet and lifestyle plan as agreed upon by the patient and health care provider team, best suited towards the patient's needs
* Throughout the study, patient will receive notifications and advice on how to follow diet and lifestyle changes
* Throughout the study; patient interaction and app usage will be tracked
* Patients will additionally be interviewed by the research team together with Droobi to capture app experience at 3 months and 6 months
Droobi
A new mobile application, specifically built for the diabetes patients in Qatar with the help of local expertise.
Standard of care
Standard of care including physicians, dietetics and diabetes educators support
Standard of care arm
For the subjects not using the app (the standard of care group):
* At time 0, will be seen by the dietician and diabetes educators at HGH endocrine clinics as part of standards of care
* The educators contact number and diabetes hotline number will be provided to the patients
o The diabetes hotline number #16099 is a new service provided to diabetes patients at the national diabetes center to help communicate with the diabetes educators with questions relating to their diabetes management, medication adjustment such as dose titrations etc.
* Appointments thereafter with the educator and/or dietician will be decided and scheduled according to the individual patient needs, with a minimum visit every 3 months during the study period
Standard of care
Standard of care including physicians, dietetics and diabetes educators support
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Droobi
A new mobile application, specifically built for the diabetes patients in Qatar with the help of local expertise.
Standard of care
Standard of care including physicians, dietetics and diabetes educators support
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Arabic speaking and non-arabic speaking T2DM patients, who can communicate in Arabic and or English language.
* Uncontrolled diabetes with HbA1c more than or equal to 8.5%
* T2DM on insulin with or without any other oral medication
* Subject must have a smart phone (must be an iOS (Apple) phone user) and must be interested in using a smart phone app.
* Subject must have no visual impairment.
* Minimal level of literacy (able to read and write in english or arabic).
* To be able to communicate via chat with the mobile app team through the app as evidenced by at least weekly use of any of the social media such as WhatsApp, Viber, Facebook Messenger etc
* Subject must be willing to utilize a mobile application for diabetes control
Exclusion Criteria
* Patients with proliferating retinopathy
* Patients with an acute illness during the past 2 weeks.
* Patients who plan to be away for more than 3 months.
* Patients with CKD requiring dialysis.
* Hypoglycemia unawareness.
* More than one episode of severe hypoglycemia in the previous 6 months.
* Female patients who are planning for pregnancy in the coming 6 months.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qatar Computing Research Institute (QCRI)
UNKNOWN
Droobi Health
UNKNOWN
Hamad Medical Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Noor N Suleiman, MD
Role: PRINCIPAL_INVESTIGATOR
Hamad Medical Corporation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hamad General Hospital
Doha, , Qatar
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Alotaibi MM, Istepanian R, Philip N. A mobile diabetes management and educational system for type-2 diabetics in Saudi Arabia (SAED). Mhealth. 2016 Aug 24;2:33. doi: 10.21037/mhealth.2016.08.01. eCollection 2016.
Cui M, Wu X, Mao J, Wang X, Nie M. T2DM Self-Management via Smartphone Applications: A Systematic Review and Meta-Analysis. PLoS One. 2016 Nov 18;11(11):e0166718. doi: 10.1371/journal.pone.0166718. eCollection 2016.
Seto E, Istepanian RS, Cafazzo JA, Logan A, Sungoor A. UK and Canadian perspectives of the effectiveness of mobile diabetes management systems. Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:6584-7. doi: 10.1109/IEMBS.2009.5333998.
Kitsiou S, Pare G, Jaana M, Gerber B. Effectiveness of mHealth interventions for patients with diabetes: An overview of systematic reviews. PLoS One. 2017 Mar 1;12(3):e0173160. doi: 10.1371/journal.pone.0173160. eCollection 2017.
Istepanian RS, Zitouni K, Harry D, Moutosammy N, Sungoor A, Tang B, Earle KA. Evaluation of a mobile phone telemonitoring system for glycaemic control in patients with diabetes. J Telemed Telecare. 2009;15(3):125-8. doi: 10.1258/jtt.2009.003006.
Ristau R, Yang J, White J. Evaluation and Evolution of Diabetes Mobile Applications: Key Factors for Health Care Professionals Seeking to Guide Patients.
Bonoto BC, de Araujo VE, Godoi IP, de Lemos LL, Godman B, Bennie M, Diniz LM, Junior AA. Efficacy of Mobile Apps to Support the Care of Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. JMIR Mhealth Uhealth. 2017 Mar 1;5(3):e4. doi: 10.2196/mhealth.6309.
Alhuwail D. Diabetes Applications for Arabic Speakers: A Critical Review of Available Apps for Android and iOS Operated Smartphones. Stud Health Technol Inform. 2016;225:587-91.
Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, Jackson RA. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005 Mar;28(3):626-31. doi: 10.2337/diacare.28.3.626.
Schmitt A, Gahr A, Hermanns N, Kulzer B, Huber J, Haak T. The Diabetes Self-Management Questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control. Health Qual Life Outcomes. 2013 Aug 13;11:138. doi: 10.1186/1477-7525-11-138.
Suleiman N, Alkasem M, Al Amer Z, Salameh O, Al-Thani N, Hamad MK, Baagar K, Abdalhakam I, Othman M, Dughmosh R, Al-Mohanadi D, Al Sanousi A, Bashir M, Chagoury O, Taheri S, Abou-Samra AB. Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus-a study protocol. Trials. 2022 Jun 16;23(1):504. doi: 10.1186/s13063-022-06334-5.
Related Links
Access external resources that provide additional context or updates about the study.
Droobi Health application website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17292
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.